Clinical Trial: Prospective Multicenter Study of Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients

U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511595) titled 'Prospective Multicenter Study of Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients' on March 30.

Brief Summary: The goal of this clinical trial is to learn whether a blood test called metagenomic next-generation sequencing (mNGS) can help diagnose invasive pulmonary fungal disease in patients with blood disorders. It will also evaluate how accurate this test is compared to traditional methods. The main questions it aims to answer are:

Can blood mNGS accurately identify the fungi causing lung infections?

How well does blood mNGS perform compared to conventional tests (such as culture, serum markers...